Previous 10 | Next 10 |
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY PR Newswire MINNEAPOLIS , April 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeScie...
The shares of Maravai LifeSciences (NASDAQ:MRVI) quickly gained on Thursday after Betaville said that the life sciences company was weighing a new buyout offer from German laboratory supplier Sartorius AG. Last February, Maravai (MRVI) shares jumped after Reuters reported that Sartorius made ...
Robinhood Markets hasn't been a great investment to own since going public last year. Down 60% and incurring losses north of $3.6 billion last year, investors don't need to look far to find safer and better growth stocks. A couple of stocks that investors should look at instead incl...
When there's a hot new field that's attracting a ton of investment and a ton of competition, sometimes it pays to invest in a company that's upstream in the value chain rather than one that's competing directly. Buying shares of key suppliers can reduce your exposure to risk, as you'll be a...
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of March. On M...
Maravai LifeSciences (MRVI +11.1%) shares surged on Friday after Reuters reported that German lab supplies vendor, Sartorius (OTCPK:SARTF) made an $11B acquisition offer for the U.S.-based life sciences company. Early this month, Maravai (NASDAQ:MRVI) turned down the $42 per share all-cash of...
Maravai LifeSciences (NASDAQ:MRVI) soared 17% after a report that Sartorius AG offered to buy the the company for $11B. Maravai rejected the $42/share offer from Goettingen, Germany-based Sartorius, according to a Reuters report. Not clear if Sartorius may return with another offer or MR...
Maravai Life Sciences (NASDAQ:MRVI) soared 17% after a report that Sartorius AG offered to buy the the company for $11B. Maravai rejected the $42/share offer from Goettingen, Germany-based Sartorius, according to a Reuters report. Not clear if Sartorius may return with another offer or M...
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participan...
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q4 2021 Earnings Call Feb 23, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2021 Earn...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...